Quick Answer
Yubo International Biotech Ltd reported Gross Profit of $8.2 thousand for fiscal year 2025.
Yubo International Biotech Ltd Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $8.2K | +208.3% |
| 2024 | $2.6K | -99.4% |
| 2023 | $419.2K | +696.1% |
| 2022 | $52.7K | -93.6% |
| 2021 | $820.6K | -33.8% |
| 2020 | $1.24M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.00 | — | — |
| June 30, 2025 | $0.00 | — | — |
| March 31, 2025 | $0.00 | -100.0% | — |
| September 30, 2024 | $0.00 | -100.0% | — |
| June 30, 2024 | $0.00 | -100.0% | -100.0% |
| March 31, 2024 | $2.7K | -95.4% | -99.2% |
| September 30, 2023 | $344.1K | +3484.2% | +38779.3% |
| June 30, 2023 | $885.00 | -84.9% | -98.5% |
- Yubo International Biotech Ltd showed an increase of +208.3% in Gross Profit compared to the prior fiscal year.
- Over the 2020–2025 period, Yubo International Biotech Ltd’s gross profit has declined by 99.3% (from $1.24 million to $8.2 thousand).
- The most recent figure is from Yubo International Biotech Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: